| Molecular modeling, synthesis, characterization and pharmacological evaluation of benzo [d] oxazole derivatives as non-steroidal anti-inflammatory agents AK Shakya, A Kaur, BO Al-Najjar, RR Naik Saudi Pharmaceutical Journal 24 (5), 616-624, 2016 | 43 | 2016 |
| Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling BO Al-Najjar, HA Wahab, TST Muhammad, AC Shu-Chien, NAA Noruddin, ... European journal of medicinal chemistry 46 (6), 2513-2529, 2011 | 42 | 2011 |
| Potential Activity of Fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. Seeds as Estrogen Receptor Antagonist Based on Cytotoxicity and Molecular Modelling … M Muchtaridi, M Yusuf, A Diantini, SB Choi, BO Al-Najjar, JV Manurung, ... International journal of molecular sciences 15 (5), 7225-7249, 2014 | 34 | 2014 |
| Arylamide as potential selective inhibitor for matrix metalloproteinase 9 (MMP9): design, synthesis, biological evaluation, and molecular modeling M Hariono, RF Nuwarda, M Yusuf, R Rollando, RI Jenie, B Al-Najjar, ... Journal of Chemical Information and Modeling 60 (1), 349-359, 2019 | 31 | 2019 |
| QSAR, in silico docking and in vitro evaluation of chalcone derivatives as potential inhibitors for H1N1 virus neuraminidase M Yaeghoobi, N Frimayanti, CF Chee, KK Ikram, BO Najjar, SM Zain, ... Medicinal Chemistry Research 25, 2133-2142, 2016 | 31 | 2016 |
| Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling L Tran, SB Choi, BO Al-Najjar, M Yusuf, HA Wahab, L Le Molecules 16 (12), 10227-10255, 2011 | 30 | 2011 |
| Structure-based drug design studies toward the discovery of novel chalcone derivatives as potential epidermal growth factor receptor (EGFR) inhibitors M Al-Anazi, BO Al-Najjar, M Khairuddean Molecules 23 (12), 3203, 2018 | 24 | 2018 |
| Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors M Al-Anazi, M Khairuddean, BO Al-Najjar, MM Alidmat, NNSNM Kamal, ... Arabian Journal of Chemistry 15 (7), 103864, 2022 | 22 | 2022 |
| Cellular and molecular basis of therapeutic approaches to breast cancer M El-Tanani, AO Al Khatib, BO Al-Najjar, AK Shakya, Y El-Tanani, YF Lee, ... Cellular signalling 101, 110492, 2023 | 16 | 2023 |
| Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients J Mohseni, BO Al-Najjar, HA Wahab, Z Zabidi-Hussin, TH Sasongko Journal of human genetics 61 (9), 823-830, 2016 | 15 | 2016 |
| Matrix metalloproteinase9 as the protein target in anti-breast cancer drug discovery: an approach by targeting hemopexin domain CF Adhipandito, DPKS Ludji, E Aprilianto, RI Jenie, B Al-Najjar, ... Future Journal of Pharmaceutical Sciences 5, 1-15, 2019 | 14 | 2019 |
| Diaminobenzene schiff base, a novel class of DNA minor groove binder MH Helal, ZA Al-Mudaris, MH Al-Douh, H Osman, HA Wahab, BO AlNajjar, ... International journal of oncology 41 (2), 504-510, 2012 | 13 | 2012 |
| Hypolipidaemic and insulin secretagogue activities of (R)-(−)-Carvone MA Abbas, GA Oriquat, MM Abbas, BO Al-Najjar, YI Kandil The Malaysian Journal of Medical Sciences: MJMS 27 (6), 39, 2020 | 10 | 2020 |
| First-pass metabolism considerations in pharmaceutical product development AK Shakya, BO Al-Najjar, PK Deb, RR Naik, RK Tekade Dosage Form Design Considerations, 259-286, 2018 | 10 | 2018 |
| P2Y12 antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studies BO Al-Najjar, FG Saqallah, MA Abbas, SZ Al-Hijazeen, OA Sibai European Journal of Medicinal Chemistry 227, 113924, 2022 | 9 | 2022 |
| Analgesic and Anxiolytic Activities of Achillea Biebersteinii: Evidence for the Involvement of GABAergic Systems SMJBOAN Manal Ahmad Abbas Oriental Journal of Chemistry 35 (4), 1433-1442, 2019 | 9 | 2019 |
| Ononis spinosa alleviated capsaicin-induced mechanical allodynia in a rat model through transient receptor potential vanilloid 1 modulation SM Jaffal, BO Al-Najjar, MA Abbas The Korean Journal of Pain 34 (3), 262-270, 2021 | 8 | 2021 |
| EGFR Inhibitors and apoptosis inducers: design, docking, synthesis, and anticancer activity of novel tri-chalcone derivatives M Al-Anazi, M Khairuddean, BO Al-Najjar, MM Alidmat, N Kamal, ... Systematic Reviews in Pharmacy 12 (3), 809-820, 2021 | 7 | 2021 |
| Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies NH Salin, R Noordin, BO Al-Najjar, EE Kamarulzaman, MH Yunus, ... Plos one 15 (5), e0225232, 2020 | 7 | 2020 |
| Pharmacophore modeling and 3D-QSAR studies of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitors BO Al-Najjar, AK Shakya, FG Saqallah, R Said NISCAIR-CSIR, India, 2017 | 7 | 2017 |
Habibah A WahabProfessor, School of Pharmaceutical Sciences, Universiti Sains Malaysia在 usm.my 的电子邮件经过验证
